Apply on Employer Site

Corcept Therapeutics · 2 months ago

Clinical Sales Specialist (CS) - Brooklyn, NY

Brooklyn, New York, United States

Full-time

Onsite

Senior Level

$140K/yr - $155K/yr

5+ years exp

Corcept Therapeutics is a leader in the research and development of cortisol modulators. The Clinical Sales Specialist is responsible for implementing sales strategies for approved products and building relationships with key healthcare providers within the assigned territory.

BiotechnologyMedicalPharmaceutical

Comp. & Benefits

Responsibilities

Build and develop professional relationships with influential high prescribers and thought leaders in the territory to enhance Corcept brand and product loyalty

Leverages expertise and knowledge of the therapeutic disease state, the marketplace, applicable competitors, industry, and cross-functional activities/plans to anticipate and effectively manage business opportunities and challenges

Develops and implements effective customer specific territory plans and communicates insights to internal stakeholders

Prioritizes time and effort to ensure optimal coverage of appropriate physician specialists based on opportunity and potential

Plan and participate in education programs and speaker dinner programs

Manage territory expenses/budget to support sales and marketing activities

Qualification

Sales experienceEndocrine relationshipsHospital sales experienceCross-functional collaborationCommunication skills

Required

BA/BS or equivalent work experience

5+ years sales experience required

Proven track record of consistent high performance

Strong ability to collaborate and work cross-functionally

Required to travel up to 100% of the time, including up to 40% overnight travel

Must maintain a driving record in accordance with Corcept vehicle policy

Able to lift and/or move up to 35 pounds

Preferred

Recent endocrine relationships

Specialty therapeutic sales experience

Hospital or orphan drugs sales experience

Company

Corcept Therapeutics

Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.

Founded in 1998

Menlo Park, California, USA

501-1000 employees

http://www.corcept.com

Funding

Current Stage

Public Company

Total Funding

$119.09M

Key Investors

Paperboy Ventures

2012-07-02IPO

2012-04-10Post Ipo Equity· $0.53M

2011-01-21Post Ipo Equity· $39M

Leadership Team

Roberto Vieira

President, Oncology

Yuan Xu

Associate Director, Statistical Programming

Recent News

pharmaphorum

Ovarian cancer data restores faith in Corcept's relacorilant

2026-01-24

Pharma Letter

Corcept says ROSELLA trial hit key endpoint for relacorilant combo

2026-01-24

legacy.thefly.com

Corcept Therapeutics reports ROSELLA trial meets primary endpoint

2026-01-23

Company data provided by crunchbase